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Abstract
Using isolated rat kidneys perfused at controlled pressure, we
examined a potential role of endothelium-derived relaxing fac-
tor (EDRF) in the pressure control of renin secretion. We
found that stimulation of EDRF release by acetylcholine (1
,tmol/liter) increased mean perfusate flow rates from 15.0±0.5
to 18.0±0.5 ml/min per g and average renin secretion rates
from 3.5±0.5 to 16.0±2.0 ng angiotensin I/h per min per g at a
perfusion pressure of 100 mmHg (mean±SEM, n = 6). Those
effects ofacetylcholine were significantly reduced during inhibi-
tion of EDRF formation with NG-nitro-L-arginine (100 ,umol/
liter), but they were not affected with the cyclooxygenase inhib-
itor indomethacin (10 ,mol/liter).
Lowering of the perfusion pressure from 100 mmHg to 40
mmHg resulted in an increase of average renin secretion rates
from 3.5±0.5 to 79±12 ng AngI/h per min per g under control
conditions (n = 8), and to 171±20 ng AngI/h per min per g in
the presence of 10 ,mol/ liter acetylcholine (n = 3). The rise of
renin secretion in response to a reduction of the renal artery
pressure was markedly attenuated with inhibitors ofEDRF for-
mation such as NG-nitro-L-arginine (100 ,umol/liter) and re-
lated compounds. During inhibition of EDRF formation, addi-
tion of sodium nitroprusside (10 ,umol/liter) increased mean
perfusate flow rates from 12.0±0.5 to 23.0±2.0 ml/min per g
and average renin secretion rates from 2.0±0.5 to 18.0±1.5 ng
AngI/h per min per g at 100 mmHg (n = 5). Lowering of the
perfusion pressure from 100 mmHg to 40 mmHg under those
conditions increased average renin secretion rates to 220±14 ng
AngI/h per min per g (n = 5).
Taken together, our findings suggest that EDRF and re-
lated activators of soluble guanylate cyclase stimulate renin
secretion from isolated kidneys, predominantly at lower perfu-
sion pressure. Moreover, pressure control of renin secretion
appears to require the tonical stimulation by intrarenal EDRF.
(J. Clin. Invest. 1993.91:1088-1094.) Key words: juxtaglomer-
ular cells * nitro-L-arginine * acetylcholine * sodium nitroprus-
side * guanylate cyclase
Introduction
Since the first demonstration by Goldblatt and co-workers ( ),
it has been well established that the intrarenal perfusion pres-
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sure is a main physiological control parameter for renin secre-
tion from the kidneys. Renin that is released from the juxtaglo-
merular (JG)' cells by regulated exocytosis indirectly increases
the blood pressure, and this effect is mediated by the vasocon-
stricting potency of angiotensin 11 (2). Thus, pressure control
of renin secretion is organized in form of a negative feedback
loop with the amount of renin released from the kidneys corre-
lating inversely with the intrarenal arterial pressure (2, 3).
The renin producing JG cells are located in the wall of the
afferent arterioles and a board of indirect evidence suggests that
also this so-called "baroreceptor" is installed within the renal
vasculature (4-6). The subcellular signaling pathways, how-
ever, along which the renal artery pressure modulates renin
secretion are not yet understood. One hypothesis existing
about this baroreceptor mechanism suggests a direct effect of
the intrarenal pressure on JG cells that is mediated by a pres-
sure-dependent stretch of the JG cell membrane (6). Experi-
mental attempts to prove such a direct pressure effect on renin
secretion from JG cells have produced controversial results.
While one group demonstrated changes ofrenin secretion from
isolated perfused rabbit afferent arterioles in response to
changes of the perfusion pressure (7), others did not report
pressure related renin secretion in a similar preparation (8).
Nonetheless, these different findings may give some hints for
the possible baroreceptor function; a pressure dependence of
renin secretion, namely, was only found with a free-flow sys-
tem allowing concomitant changes of flow in response to
changes of the perfusion pressure (7), but not with a stop-flow
system permitting modulation of the hydrostatic pressure only
(8). Those results could indicate that baroreceptor function
requires flow through the afferent arterioles and therefore di-
recting attention towards a possible role of endothelial cells in
the pressure control of renin secretion.
Endothelial cells in fact have properties making them suit-
able for mechanotransduction. For instance they are equipped
with ion channels that become activated during increased shear
stress (9, 10). Moreover, they release vasoactive autacoids such
as endothelium-derived relaxing factor (EDRF), which is con-
sidered to be nitric oxide (NO) ( 11 ), in a flow-dependent fash-
ion ( 12, 13). Recent evidence suggests that the activation of
shear stress-sensitive potassium channels is causally involved
in the release ofEDRF ( 14). Furthermore, it has been demon-
strated that endothelial cells can modulate renin secretion from
isolated JG cells in primary culture ( 15).
Nonetheless, the physiological role ofthe vascular endothe-
lium in the control of renin secretion is not known. Also the
1. Abbreviations used in this paper: Ang, angiotensin; ANP, atrial natri-
uretic peptide; D-NNA, NG-nitro-D-arginine; EDRF, endothelium-de-
rived relaxation factor; GFR, glomerular filtration rate; JG, juxtaglo-
merular (cells); L-NAME, nitro-L-argininemethylester; L-NNA, NG-
nitro-L-arginine; NMMA, NG-monomethylarginine; NO, nitric oxide;
RSR, renin secretion rate; SNP, sodium nitroprusside.
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effect of EDRF on renin secretion is not unequivocal. There
are indirect observations, suggesting either a stimulatory ( 15)
or an inhibitory effect ofEDRF on renin release in vitro ( 16).
In view of this background, it appeared reasonable to us to
examine a possible physiological role of EDRF in the regula-
tion of renin secretion, in particular, in the control of renin
release by the renal perfusion pressure. To this end, we have
systematically examined to what extent stimulation or inhibi-
tion ofEDRF formation modulates the pressure dependence of
renin secretion from isolated perfused rat kidneys. We used the
model of isolated rat kidneys perfused at controlled pressure
because we have previously found that the amount of renin
released from this preparation correlates inversely with the
renal artery pressure and also the basic mechanisms of myo-
genic autoregulation are preserved under those condi-
tions ( 17 ).
Methods
Isolated perfused rat kidney. Male SIV strain rats (250-350 g body wt)
having free access to commercial pellet chow and tap water were ob-
tained from the local animal house and used throughout. Kidney per-
fusion was performed in a recycling system according to the technique
of Schurek and Alt ( 18) with minor modifications as described previ-
ously ( 19). In brief, the animals were anesthetized with 150 mg/kg of
5-ethyl-( 1'-methyl-propyl)-2-thio-barbituric acid (Inactin®; BYK
Gulden, Konstanz, Germany). Volume loss during the preparation
was substituted by intermittent injections of physiologic saline (- 2.5
ml totally) via a catheter which was inserted into the jugular vein. After
opening of the abdominal cavity by a midline incision the right kidney
was exposed and placed in a thermostatically controlled metal
chamber. The right ureter was cannulated with a small polypropylene
tube ( PP- 10) that was connected to a larger polyethylene catheter ( PE-
50; Labotrade, Schonenbuch, Switzerland). After intravenous heparin
injection (2 U/g Liquemin®; Roche, Basel, Switzerland) the aorta was
clamped distal to the right renal artery and the large vessels branching
off the abdominal aorta were ligated. A double-barreled cannula was
inserted into the abdominal aorta and placed closely to the origin ofthe
right renal artery. After ligation of the aorta proximal to the right renal
artery the aortic clamp was quickly removed and perfusion was started
in situ with an initial flow rate of 8 ml/min. The right kidney was
excised and perfusion at constant pressure (100 mmHg) was estab-
lished. To this end, the renal artery pressure was monitored through the
inner part of the perfusion cannula (Statham transducer P 10 EZ:
Gould, Spectramed Ltd., Coventry, UK) and the pressure signal was
used for feedback control of a peristaltic pump. The perfusion circuit
was closed by draining the renal venous effluent via a metal cannula
back into a reservoir (200-220 ml). The basic perfusion medium,
which was taken from the thermocontrolled (370C) reservoir, con-
sisted ofa modified Krebs-Henseleit solution containing all physiologic
amino acids except L-arginine in concentrations between 0.2 and 2.0
mM, and 8.7 mM glucose, 0.3 mM pyruvate, 2.0 mM L-lactate, 1.0
mM a-ketoglutarate, 1.0 mM L-malate, 6.0 mM urea, and 1 mU 100
ml vasopressin 8-lysine. The perfusate was supplemented with 6 g/ 100
ml BSA and with freshly washed human red blood cells ( 10±2% hemat-
ocrit). Ampicillin (3 mg/100 ml) and flucloxacillin (3 mg/100 ml)
were added to inhibit possible bacterial contamination ofthe medium.
To improve the functional preservation ofthe preparation, the perfus-
ate was continuously dialysed against a 25-fold volume of the same
composition but without containing erythrocytes and albumin. For
oxygenation of the perfusion medium the dialysate was gassed with a
95% oxygen/5% carbon dioxide mixture. Perfusate flow rate was ob-
tained from the revolutions of the peristaltic pump that was calibrated
before and after each experiment. Renal flow rate and perfusion pres-
sure were continuously monitored by a potentiometric recorder (Kipp
& Zonen, Delft, Netherlands). Stock solutions ofthe drugs to be tested
(see below) were dissolved in freshly prepared perfusate and infused
into the arterial limb ofthe perfusion circuit directly before the kidneys
(peristaltic pump 2132 Microperpex®; LKB, Bomma, Sweden) at 1%
ofthe rate ofperfusate flow. For determination ofperfusate renin activ-
ity (pRA) aliquots (100 ,tl) were drawn from the arterial limb of the
circulation and the renal venous effluent, respectively. The samples
were centrifuged (4"C) at 1,500 g for 15 min (Sorvall RT 6000; Sor-
vall) and the supernatants were stored at -20'C until assayed for renin
activity.
Determination of renin activity. Perfusate samples were incubated
for 1.5 h at 370C with plasma of bilaterally nephrectomized male rats
as renin substrate (20). The generated angiotensin I was determined by
radioimmunoassay (Medipro AG, Teufen, Switzerland).
Renin release. In a previous study performed with the same experi-
mental model, we have found that renin is not inactivated during its
passage through isolated perfused rat kidneys ( 19). Therefore, renin
secretory rates were calculated from the arteriovenous differences of
perfusate renin activity and the corresponding renal flow rates.
Chemicals. Acetylcholine, L-arginine, NG-nitro-L-arginine, nitro-L-
argininemethylester, sodium nitroprusside, 8-bromo-cGMP, rat syn-
thetic atrial natriuretic peptide, indomethacin, and isoproterenol were
purchased from Sigma International. N0-monomethylarginine and
N0-nitro-D-arginine were obtained from Calbiochem (Lucerne, Swit-
zerland) and from Serva (Heidelberg, Germany), respectively.
Presentation of results. Graphs showing renal perfusate flow and
renin secretion rates are exact redrawings from original traces. All ex-
periments were performed according to standard protocols and each
point represents the mean ofn experiments. Perfusate samples for deter-
mination of renin activity were collected in 2-min intervals and this is
indicated (0) in Figs. 2-6. Asterisks indicate the first value being signifi-
cant vs. controls.
Statistical analysis. The same kidneys were first taken as controls
and were then used for the experimental protocols. Levels of signifi-
cance were calculated using paired Student's t test. P < 0.05 was consid-
ered significant.
Results
Basal perfusate flow rates through the isolated rat kidneys per-
fused at 100 mmHg were 15.0±0.5 ml/min per g
(mean±SEM; n = 15) and basal renin secretion rates were
3.5±0.5 ng Angiotensin I (AngI)/h per min per g (n = 15).
To obtain first evidence whether EDRF modulates renin
secretion from whole kidneys at all, the hormone acetylcho-
line, which is a well-known activator of endothelial EDRF re-
lease (21), was added to the perfusate. Acetylcholine used in
the concentration range between 10 nmol/liter and 1 ,umol/
liter caused a dose dependent increase of perfusate flow rate
and also led to a graded stimulation of renin secretion at a
perfusion pressure of 100 mmHg (Fig. 1). At a concentration
of 1 gmol/liter acetylcholine, renin secretion rates were in-
creased from the basal level of 3.5±0.5 to 16.0±2.0 ng AngI/h
per min per g (n = 6). In parallel, urine flow rates increased
from 71±14 ,l/min per g under control conditions to maxi-
mally 159±30 ,ul/min per g with 1 ,imol/liter acetylcholine (n
=6).
NG-nitro-L-arginine (L-NNA; 100 pmol/liter), an inhibi-
tor of EDRF formation (22), significantly reduced the renal
vascular relaxation and abolished the enhancement of renin
secretion produced by acetylcholine ( 1 tmol/liter). Within the
same kidneys the vasodilating and renin stimulatory effect of
acetylcholine could be partially restored by removing L-NNA
from the perfusion medium and by adding 1 mmol/liter of
L-arginine (Fig. 2).
EDRF is considered to act in its target cells by activating the
soluble guanylate cyclase and thereby increasing the cellular
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Figure 1. Perfusate flow rates and renin secretion rates in isolated rat
kidneys perfused at a constant pressure of 100 mmHg in the presence
ofgraded concentrations of acetylcholine. Data are means±SEM of
six kidneys. Asterisks indicate P < 0.05 vs. control.
cyclic GMP levels (23). We therefore assessed the effect of
atrial natriuretic peptide (ANP), which is an activator ofpartic-
ulate guanylate cyclase (24) on renin secretion from our prepa-
rations. As shown in Table I, ANP ( 100 pmol/liter, and 1
nmol/ liter) led to a dose dependent increase of renin secretion
rates to maximal values of 11.0±3.0 ng AngI/h per min per g
(n = 5). At both concentrations used, ANP did not change
perfusate flow through the kidneys. Also, the membrane perme-
able cyclic GMP analogue 8-bromo-cyclic GMP (100 ,mol/
liter) significantly increased renin secretion rates to 12.0±2.5
ng AngI/h per min per g (n = 3). For comparison, addition of
10 nmol/liter isoproterenol, which stimulates renin release
through a cyclic AMP dependent mechanism (2), resulted in
renin secretion rates of 55.0±5.0 ng AngI/h per min per g
(n= 5).
Since acetylcholine not only enhances EDRF formation in
endothelial cells but also the release ofprostacyclin (25), which
in turn might stimulate renin secretion (26), we used indo-
methacin to inhibit prostacyclin synthesis. As shown in Fig. 3,
indomethacin (10Ismol/liter) had no significant influence nei-
ther on basal flow nor on renin secretion rates. In particular,
indomethacin did not affect the vasorelaxing and renin stimula-
tory effects of acetylcholine (Fig. 3).
A possible role ofendogenous EDRF release in the kidneys
on pressure-controlled renin secretion was assessed by investi-
gating the effects of three different inhibitors of EDRF forma-
tion, namely NG-nitro-L-arginine (L-NNA; 100 ,umol/liter),
nitro-L-argininemethylester (L-NAME; 100 ,umol/liter) and
NG-monomethylarginine (NMMA; 200 pomol/liter) on renin
secretion. As shown previously, stepwise reductions of the
renal artery pressure in the range between 100 mmHg and 40
mmHg result in exponentially increasing renin secretion rates
in this preparation ( 17). As a standard protocol to stimulate
pressure related renin release a single pressure step from 100
mmHg to 40 mmHg was therefore performed. Under control
conditions this maneuver led to an increase of renin secretion
from 3.5±0.5 to 79±12 ng AngI/h per min per g (n = 8) (Fig.
4). In the presence ofL-NNA ( 100 tLmol/ liter), perfusate flow
rates significantly decreased from 15.0±0.5 to 12.0±0.5 ml/
min per g (n = 8) (Table II) and also renin secretion rates
tended to decrease at 100 mmHg (Fig. 4). More clearly, the rise
of renin secretion in response to a reduction of the perfusion
pressure to 40 mmHg was significantly attenuated in the pres-
ence of 100 ,gmol/liter L-NNA ( 13±3 vs. 79±12 ng Angl/h per
min per g). About 50% of the normal pressure response of
renin secretion could be restored by removing L-NNA from the
perfusate and by adding 1 mmol/liter of L-arginine (Fig. 4).
To test for the specificity of the effects obtained with L-
NNA, we also investigated the influence of N0-nitro-D-argi-
nine (D-NNA), a stereoisomer without inhibitory effect on
EDRF formation (27). D-NNA ( 100 ,gmol/liter) did not alter
renal flow rates and even slightly improved the pressure re-
sponse of renin secretion, while L-NNA ( 100 ,umol/liter) al-
most blunted the rise of renin release in the same kidneys (Fig.
5). For control, we examined as to whether L-NNA did also
affect the renin stimulatory potency of isoproterenol, which
activates renin secretion via cyclic AMP formation (2). As
shown in Fig. 5, isoproterenol used at a concentration of 10
nmol/liter, even in the presence of L-NNA and also during
D-NNA administration, significantly increased renin secretion
rates. Similar to L-NNA, L-NAME, and NMMA, two other
inhibitors ofEDRF formation, also significantly reduced renin
release at a renal artery pressure of 40 mmHg (Table II). On a
molar basis, L-NNA and NMMA were more potent than L-
NAME in decreasing renin secretion at a perfusion pressure of
40 mmHg (Table II). Like L-NNA, L-NAME, and NMMA
also significantly reduced perfusate flow rates to 13.0±0.5 and
12.5±0.5 ml/min per g (n = 3), respectively (Table II). All
three inhibitors of EDRF formation did not significantly
change urine flow rates (Table II).
Assuming that a fall ofthe renal artery pressure requires the
release of EDRF to become an effective stimulus for renin re-
lease, we tested as to whether pressure related renin secretion
could be reestablished by mimicking NO release during inhib-
ited EDRF formation. To this end, we examined pressure-de-
pendent renin secretion in the combined presence ofan EDRF
inhibitor (L-NNA) and of an exogenous nitrate (sodium nitro-
prusside [SNP] ) that mimicks the action of EDRF. As shown
in Fig. 6, the addition ofSNP ( 10 jimol / liter) in the presence of
L-NNA ( 100 ,umol/liter) led to a prompt increase of perfusate
flow rates from 12.0±0.5 to 23.0±2.0 ml/min per g (n = 5 ) and
to an increase ofrenin secretion rates from 2.0±0.5 to 18.0±1.5
ng AngI/h per min per g (n = 5) at 100 mmHg. When the
Nitro-L-Arginine 100 pM L-Arginine 1mM
Acetylcholine
A
@
0 E.
~
_L E
pM
12-
8-1
B-,c 30-
.s- 20-
x:I 10- oo
_ 0+0--v °0-§0
cr
'
0
'0-o-o o
5min
Figure 2. Perfusate flow rates (A) and renin secretion rates (B) in
isolated rat kidneys perfused at 100 mmHg in the absence and pres-
ence of 1 ,umol /liter acetylcholine and 100 ,mol /liter NG-nitro-L-ar-
ginine. Each point represents mean±SE of three kidneys. Asterisks
indicate the first values being significantly different from control P
<0.05.
1090 H. Scholz and A. Kurtz
o RSR
* Flow rate
Table I. Effects ofANP, 8-bromo-cGMP, and Isoproterenol on Renin Secretion Rates (RSR) in Isolated Kidneys Perfused at Constant
Pressure of100 mmHg
Control ANP ANP 8-bromo-cGMP Isoproterenol
100 pmol/tlier I nmol/liler 100 ,gmol/liter 10 nmol/liter
RSR ng AngI/h per min per g 3.5±0.5 5.5±1.0 11.0±3.0* 12.0±2.5* 55.0±5.0*
(5) (3) (5) (3) (5)
The number of experiments is given in parentheses. Data are expressed as ±SEM. Asterisks indicate P < 0.05 vs. controls.
perfusion pressure was then reduced to 40 mmHg in the com-
bined presence ofL-NNA ( 100 ,gmol/liter) and SNP 10 ,umol/
liter), renin secretion rates increased to 220± 14 ng AngI / h per
min per g (Fig. 6).
Finally, we examined whether the pressure dependence of
renin secretion was altered under conditions of stimulated
EDRF release. To this end, renin secretion rates in the absence
and in the presence of acetylcholine were determined in the
same kidneys at perfusion pressures of 140, 100, and 40
mmHg. As shown in Fig. 7, acetylcholine used at a concentra-
tion of 10 timol/liter significantly altered the relationship be-
tween perfusion pressure and renin secretion, in a way that it
weakly increased renin release at high pressure and potently
enhanced renin secretion at low perfusion pressure: At a renal
artery pressure of 140 mmHg, acetylcholine (10 ,gmol/liter)
did not significantly affect renin secretion rates, whereas a sig-
nificant increase of renin release from 3.5±0.5 to 17.0±2.5 ng
AngI/h per min per g (n = 3) was obtained at 100 mmHg (Fig.
7). When the perfusion pressure was reduced to 40 mmHg,
renin secretion rates increased to maximal values of 171±20 ng
AngI /h per min per g (n = 3) in the presence of acetylcholine
(Fig. 7).
Discussion
The aim of this study was to investigate a possible involvement
of EDRF in the pressure control of renin secretion from the
kidneys, which is commonly referred to as the intrarenal barore-
ceptor mechanism of renin secretion. As an experimental
model, we used an isolated rat kidney preparation perfused
with a medium containing red blood cells, which is suitable to
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study the regulation of renin secretion at the organ level ( 17,
19). In particular, this model displays an inverse relationship
between perfusion pressure and renin release (Fig. 7, reference
17) in a fashion similar to the in vivo situation (28). Moreover,
we have recently demonstrated that the basic mechanisms of
myogenic autoregulation of flow are preserved ( 17) and also
characteristic signal transduction mechanisms such as angio-
tensin II induced inhibition or isoproterenol related stimula-
tion of renin release are operating under those experimental
conditions ( 17, 19).
We found that acetylcholine, which activates the formation
of endothelial autacoids such as EDRF also in renal vascular
beds (21, 29), caused a dose dependent decrease in vascular
resistance and an increase in renin secretion rates (Fig. 1).
Since these effects of acetylcholine were reversibly suppressed
in the presence of an established inhibitor of EDRF formation
(Fig. 2), it appears most likely that the vasorelaxing and the
renin stimulatory action of acetylcholine were both mediated
by EDRF. In the same kidney preparations inhibition ofprosta-
glandin synthesis with indomethacin did not affect neither
renal vascular relaxation nor the stimulation of renin release
caused by acetylcholine (Fig. 3) and a possible involvement of
prostacyclin in the actions of acetylcholine becomes therefore
less likely (30). A vasodilating effect of acetylcholine in the
isolated perfused rat kidney is in keeping with previous studies
(31, 32) as well as with a more general concept indicating a role
of the vascular endothelium, particularly of EDRF, in the va-
sorelaxant action of acetylcholine (33). Stimulation of renin
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Figure 3. Effect of indomethacin ( 10 ,umol / liter) on renal flow rates
(A) and renin secretion rates (B) in the absence and presence of ace-
tylcholine (1 4smol/liter). Data are means±SEM of five kidneys. As-
terisks indicate the first values being significantly different vs. controls
P < 0.05.
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Figure 4. Perfusate flow rates (A) and renin secretion rates (B) in
isolated rat kidneys perfused at 100 mmHg and 40 mmHg in the
presence of 100 ,umol/liter NG-nitro-L-arginine or 1 mmol/liter L-ar-
ginine. Data are means±SEM of eight kidneys. Asterisks indicate the
first values being significantly different from controls P < 0.05.
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Table 11. Effects ofL-NNA, L-NAME, andNMMA on RSR, Perfusate Flow, and Urine Flow in Isolated Perfused Rat Kidneys
Control L-NNA L-NAME NMMA
100 Mmol/liter 100 jmol/l1iter 200 Mmol/liter
RSR ng AngI/h per min per g
at 40 mmHg 79±12 (8) 13±3* (8) 31±6* (3) 10±2* (3)
Flow rate ml/min per g
at 100 mmHg 15.0±0.5 (8) 12.0±0.5* (8) 13.0±0.5* (3) 12.5±0.5* (3)
Urine flow ml/min per g
at 100 mmHg 71±14 (8) 68±5 (8) 77±10 (3) 75±7 (3)
The number of experiments is given in parentheses. Data are means±SEM. Asterisks indicate P < 0.05 vs. control.
release by acetylcholine has previously been reported for dogs
(34) and turtles (35). A stimulatory effect of EDRF on renin
secretion is also supported by our finding that inhibition of
EDRF synthesis led to a decrease ofbasal renin release (Fig. 2).
This observation is in good accordance with a recent study
reporting that renin secretion from isolated rat kidneys per-
fused at a constant renal artery pressure of80 mmHg was signif-
icantly reduced with nitro-L-arginine, an inhibitor of EDRF
formation (36). A similar finding was made in anesthetized
dogs in which blockade of NO synthase caused a decrease of
plasma renin activity (37). A stimulatory effect of EDRF on
renin secretion is also supported by our recent cell coculture
study with isolated juxtaglomerular cells and vascular endothe-
lial cells ( 15), but it is at variance with another in vitro study
performed on kidney slices and suggesting an inhibitory action
ofEDRF on renin release ( 16).
In view ofthe latter discrepancy, it must be considered that
acetylcholine induced stimulation of renin secretion as ob-
served in this study was possibly related to changes of flow or
was mediated by the macula densa mechanism rather than
being caused by a direct stimulatory effect of EDRF on JG
cells. However, since acetylcholine increased renin release pre-
dominantly at lower pressure values without affecting renal
flow rates in this pressure range (Fig. 7), the stimulation of
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Figure 5. Perfusate flow rates (A) and renin secretion rates (B) in an
isolated rat kidney perfused at 100 and 40 mmHg in the presence of
100 ,umol/liter N-Gnitro->Darginine or 100 tLmol/liter N'-nitro-L-ar-
ginine. In the presence ofboth drugs, renin secretion was stimulated
by 10 nmol/liter isoproterenol. The combination of experiments
shown in this figure was done with two kidneys, which produced very
similar results. Original redrawing from the recordings ofone of these
experiments is shown.
renin secretion in response to acetylcholine was probably not
mediated by parallel changes of flow. Moreover, acetylcholine
also significantly increased urine flow rates at a perfusion pres-
sure of 100 mmHg, and if there was an effect on glomerular
filtration rate (GFR) at all, one should therefore expect that
acetylcholine enhanced rather than decreased GFR (32). As a
consequence, the tubular sodium chloride delivery should if at
all increase, thereby causing inhibition rather than a stimula-
tion of renin secretion via the macula densa mechanism (38).
A major pathway along which EDRF exerts its cellular ef-
fects is via stimulation of soluble guanylate cyclase activity
leading to a rise of intracellular cGMP levels (23). The role of
cGMP in the control ofrenin secretion is not yet unequivocally
understood. Membrane permeable cGMP analogues such as
8-bromo-cGMP have been found either to inhibit renin release
from kidney slices (39) and from cultured JG cells (39, 40) or
to have no effect on renin secretion from kidney slices (41) and
isolated perfused kidneys (42). Also experiments with ANP, an
activator of particulate guanylate cyclase (24), have produced
divergent results. Thus, ANP has been found to inhibit (39) or
to stimulate (41) renin secretion in vitro from kidney slices and
to decrease renin release from cultured JG cells (43) and in
vivo upon systemic application (44). Intrarenal infusion of
ANP into conscious dogs (45), as well as application ofANP
into isolated perfused rat kidneys (46), however, has been ob-
served to stimulate renin release. The findings obtained in this
study would suggest that an increase ofrenal cGMP levels has a
stimulatory rather than an inhibitory effect on renin secretion.
Whether this effect is due to a direct action ofcGMP in JG cells
Sodium Nitroprussido 10pM Figure 6. Perfusate flow
Nitro-L-Arginine 100PM rates (A) and renin se-
40 40 4OmmHg cretion rates (B) in iso-
20 lated rat kidneys per-
c-i 151+ fused at 100 and 40GE 10] mmHg in the absence
s- 1 and presence of 100
B. 200- Amol/liter
160- N-nitro-L-arginine and
120 in the combined pres-
z1 ] | ~~~~~~~enceof 100 ,umol/liter80 N-nitro-L-arginine and
o> 40 u10Mmol/liter SNP.
0- Data are means±SEM
5 min of five kidneys. Aster-
isks indicate the first values being significantly different vs. controls
P < 0.05.
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Figure 7. Relationship
200- between renin secretion
rates and perfusion
m
150 pressure in isolated per-
:S \fused rat kidneys in the
Ex \absence and in the pres-
c100- \ ence of 10IOmol/liter
50 acetylcholine. Renin se-
c
< 50- i \*cretion rates were deter-
c mined 6 min after pres-
0 sure steps from 100 to
0 20 40 60 80 100 120 140 140 or 40 mmHg, which
Perfusion Pressure (mmHg) were performed first in
the absence and then in
the presence of acetylcholine in the same kidneys. Data are
means±SE of three kidneys. Asterisks indicate P < 0.05 vs. absence
of acetylcholine. o, Control; *, acetylcholine (10 AsM).
or indirectly mediated by other cells cannot be distinguished
from our experiments with whole kidneys. It is also possible
that the stimulatory effect ofEDRF on renin secretion was not
related to cGMP formation because there is accumulating evi-
dence for biologic effects of EDRF/NO that are not linked to
cGMP formation (47, 48).
Irrespective of the molecular mechanism by which EDRF
enhances renin secretion from whole kidneys, our findings also
show that the enhancement ofrenin release from the kidneys in
response to a reduction of the perfusion pressure was almost
blunted in the presence of drugs (Fig. 4, Table II), that are
commonly considered to inhibit EDRF formation ( 13, 22, 49,
50). The following lines of evidence support the specific action
of these inhibitors ofEDRF synthesis on renin release: Firstly,
the effects ofL-NNA and related compounds could partially be
reversed by the addition of higher concentrations of L-arginine
(Figs. 2 and 4) which is an established maneuver to restore
inhibited EDRF formation (49). Secondly, nitro-D-arginine, a
stereoisomer of nitroarginine, which is presumed not to block
EDRF synthesis (27), also did not attenuate the pressure de-
pendence of renin secretion (Fig. 5). Thirdly, the stimulatory
effect of isoproterenol, which directly enhances renin secretion
by increasing cellular cAMP levels (2) was not influenced dur-
ing inhibition of EDRF formation (Fig. 5). Finally, substitu-
tion of EDRF by an artificial analogue, such as SNP reestab-
lished the pressure dependence of renin secretion, even in the
presence of inhibitors of EDRF synthesis (Fig. 6).
Taken together, we infer from our findings that EDRF is a
stimulatory signal for renin secretion in the kidneys, and we
suggest that tonically released EDRF accounts for the rise of
renin secretion caused by a fall of the perfusion pressure.
The question arises as to whether the typical inverse rela-
tionship between renin secretion and renal artery pressure re-
sults from a pressure-dependent formation of EDRF, in a way
that EDRF release is low at high pressure and high at low pres-
sure. Another possibility would be that the release ofEDRF is
less pressure dependent, but that the stimulatory effect of
EDRF on renin secretion is counterbalanced by a second pres-
sure related process. We attempted to distinguish between both
possibilities by assaying cGMP in the venous renal effluent as
an indirect measure for renal EDRF activity. However, cGMP
concentrations in the perfusate were below the detection limit
of the radioimmunoassay used (< 25 fmol/ml), thus allowing
no information about pressure dependent formation ofEDRF
in the kidneys.
Nonetheless, we think that there are two lines of indirect
evidence suggesting that the effect ofEDRF on renin secretion
from JG cells rather than the formation of EDRF itself was
controlled by the perfusion pressure. Thus, acetylcholine pro-
duced a potent EDRF dependent vasodilation at 100 mmHg
(Fig. 2), indicating that the release of higher quantities of
EDRF can principally occur in this pressure range. At the same
time there was only a relatively weak EDRF dependent stimula-
tion ofrenin secretion at 100 mmHg, but a powerful increase of
renin release with decreasing perfusion pressure (Fig. 7). Simi-
larly, mimicking the effect of EDRF on soluble guanylate cy-
clase activity with SNP markedly decreased vascular resistance
but only weakly stimulated renin secretion at 100 mmHg (Fig.
6). Similar to acetylcholine the stimulatory effect of SNP on
renin secretion became enhanced by lowering the perfusion
pressure to 40 mmHg (Fig. 6).
Taken together, our findings are compatible with the con-
cept that the baroreceptor mechanism controlling renin secre-
tion consists of at least two components. A tonical stimulatory
one provided by the continuous release of EDRF from the
vascular endothelium or from other cellular structures of the
kidney. And a second inhibitory one, that is directly related to
the perfusion pressure and that is enough potent to neutralize
the stimulatory influence ofEDRF at higher pressure values.
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